BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30130329)

  • 1. Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients.
    Ruck JM; Jackson AM; Massie AB; Segev DL; Desai N; Garonzik-Wang J
    Transplantation; 2019 Jun; 103(6):1267-1271. PubMed ID: 30130329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size.
    Ashby VB; Leichtman AB; Rees MA; Song PX; Bray M; Wang W; Kalbfleisch JD
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1148-1160. PubMed ID: 28596416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Yacoub R; Nadkarni GN; Cravedi P; He JC; Delaney VB; Kent R; Chauhan KN; Coca SG; Florman SS; Heeger PS; Murphy B; Menon MC
    Kidney Int; 2018 Feb; 93(2):482-490. PubMed ID: 28965746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG
    Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
    Opelz G; Döhler B
    Transplantation; 2010 Aug; 90(3):292-7. PubMed ID: 20548266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
    Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
    J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation.
    Opelz G; Döhler B
    Tissue Antigens; 2013 Oct; 82(4):235-42. PubMed ID: 24461002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQ Mismatching and Kidney Transplant Outcomes.
    Leeaphorn N; Pena JRA; Thamcharoen N; Khankin EV; Pavlakis M; Cardarelli F
    Clin J Am Soc Nephrol; 2018 May; 13(5):763-771. PubMed ID: 29685925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: a Markov decision process model.
    Van Arendonk KJ; Chow EK; James NT; Orandi BJ; Ellison TA; Smith JM; Colombani PM; Segev AD
    Transplantation; 2015 Feb; 99(2):360-6. PubMed ID: 25594552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation.
    Khongjaroensakun N; Kitpoka P; Wiwattanathum P; Sakulchairungrueng B; Thammanichanond D
    Transplant Proc; 2018 Oct; 50(8):2371-2376. PubMed ID: 30316360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
    Adekoya AO; Halawa A
    Exp Clin Transplant; 2016 Feb; 14(1):32-7. PubMed ID: 26862822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.